Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing anchored RBD: a randomised, observer-blind, phase 1 study https://www.medrxiv.org/content/10.1101/2022.11.21.22281000
Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing anchored RBD: a randomised, observer-blind, phase 1 study https://www.medrxiv.org/content/10.1101/2022.11.21.22281000